$TEVA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in TEVA PHARMACEUTICAL INDUSTRIES LTD. Get notifications about new insider transactions in TEVA PHARMACEUTICAL INDUSTRIES LTD for free.

Page:   < prev 1 2 3 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 20 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseM0.001,24100
Sep 20 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...SellS7.834943,8692,1352.6 K to 2.1 K (-18.79 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...BuyM0.001,24102,6291.4 K to 2.6 K (+89.41 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseM0.002,63800
Sep 20 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...SellS7.829627,52310,67811.6 K to 10.7 K (-8.26 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...BuyM0.002,638011,6409 K to 11.6 K (+29.30 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...Option ExerciseM0.004,09100
Sep 20 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...SellS7.831,40611,01115,44516.9 K to 15.4 K (-8.34 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...BuyM0.004,091016,85112.8 K to 16.9 K (+32.06 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.002,37600
Sep 20 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS7.832,37618,60702.4 K to 0 (-100.00 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.002,37602,3760 to 2.4 K
Sep 20 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseM0.001,44600
Sep 20 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...BuyM0.001,446010,5959.1 K to 10.6 K (+15.81 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.002,48900
Sep 20 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS7.821,1769,1971,6762.9 K to 1.7 K (-41.23 %)
Sep 20 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.002,48902,852363 to 2.9 K (+685.67 %)
Sep 11 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.006960698
Sep 11 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS7.163332,384363696 to 363 (-47.84 %)
Sep 11 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.0069606960 to 696
Jun 13 2019TEVATEVA PHARMACEUTICA ...Nisen PerryDirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...MIGNONE ROBERTODirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...Halfon Jean MichelDirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...Crane Rosemary ADirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...Satchi-Fainaro RonitDirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...Peres Nechemia JacobDirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...LIEBERMAN GERALD MDirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...GOLDBERG MURRAY ADirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...Elstein AmirDirectorOption ExerciseA0.0017,621017,621
Jun 13 2019TEVATEVA PHARMACEUTICA ...BARER SOL JDirectorOption ExerciseA0.0031,388031,388
Jun 05 2019TEVATEVA PHARMACEUTICA ...BARER SOL JDirectorBuyP9.60104,5001,003,409220,442115.9 K to 220.4 K (+90.13 %)
Jun 03 2019TEVATEVA PHARMACEUTICA ...BARER SOL JDirectorBuyP8.98111,000997,013115,9424.9 K to 115.9 K (+2,246.05 %)
May 21 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...Option ExerciseM0.0030,87500
May 21 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...SellS11.4216,070183,51933,58949.7 K to 33.6 K (-32.36 %)
May 21 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...BuyM0.0030,875049,65918.8 K to 49.7 K (+164.37 %)
May 20 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...Option ExerciseM0.001,20400
May 20 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...SellS11.766297,39718,78419.4 K to 18.8 K (-3.24 %)
May 20 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...BuyM0.001,204019,41318.2 K to 19.4 K (+6.61 %)
May 20 2019TEVATEVA PHARMACEUTICA ...LIEBERMAN GERALD MDirectorOption ExerciseM0.002,78000
May 20 2019TEVATEVA PHARMACEUTICA ...LIEBERMAN GERALD MDirectorBuyM0.002,780010,3427.6 K to 10.3 K (+36.76 %)
May 20 2019TEVATEVA PHARMACEUTICA ...Halfon Jean MichelDirectorOption ExerciseM0.002,78000
May 20 2019TEVATEVA PHARMACEUTICA ...Halfon Jean MichelDirectorBuyM0.002,78004,9422.2 K to 4.9 K (+128.58 %)
May 20 2019TEVATEVA PHARMACEUTICA ...Elstein AmirDirectorOption ExerciseM0.002,78000
May 20 2019TEVATEVA PHARMACEUTICA ...Elstein AmirDirectorBuyM0.002,78001,998,6482 M to 2 M (+0.14 %)
May 20 2019TEVATEVA PHARMACEUTICA ...Crane Rosemary ADirectorOption ExerciseM0.002,78000
May 20 2019TEVATEVA PHARMACEUTICA ...Crane Rosemary ADirectorBuyM0.002,780010,7928 K to 10.8 K (+34.70 %)
May 20 2019TEVATEVA PHARMACEUTICA ...BARER SOL JDirectorOption ExerciseM0.002,78000
May 20 2019TEVATEVA PHARMACEUTICA ...BARER SOL JDirectorBuyM0.002,78004,9422.2 K to 4.9 K (+128.58 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseM0.001,17901,179
Mar 19 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...SellS16.631,17919,6011,3882.6 K to 1.4 K (-45.93 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...BuyM0.001,17902,5671.4 K to 2.6 K (+84.94 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseM0.008720874
Mar 19 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...SellS16.643205,3269,0029.3 K to 9 K (-3.43 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...BuyM0.0087209,3228.5 K to 9.3 K (+10.32 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.001,29701,297
Mar 19 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS16.641,29721,58801.3 K to 0 (-100.00 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.001,29701,2970 to 1.3 K
Mar 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...Option ExerciseM0.002,35802,359
Mar 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...SellS16.432,35838,7422,9745.3 K to 3 K (-44.22 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...BuyM0.002,35805,3323 K to 5.3 K (+79.29 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...Option ExerciseM0.006600661
Mar 19 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...SellS16.632303,82412,76013 K to 12.8 K (-1.77 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...BuyM0.00660012,99012.3 K to 13 K (+5.35 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.009430944
Mar 19 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS16.6394315,6770943 to 0 (-100.00 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.0094309430 to 943
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.002650266
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.007470748
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS16.63931,54616,75016.8 K to 16.8 K (-0.55 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS16.632634,37216,84317.1 K to 16.8 K (-1.54 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.00265017,10616.8 K to 17.1 K (+1.57 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.00747016,84116.1 K to 16.8 K (+4.64 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseM0.001,17901,179
Mar 19 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...SellS16.6363210,5079,1499.8 K to 9.1 K (-6.46 %)
Mar 19 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...BuyM0.001,17909,7818.6 K to 9.8 K (+13.71 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...Option ExerciseM0.002,44400
Mar 14 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...SellS15.822,44438,6642,9745.4 K to 3 K (-45.11 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...BuyM0.002,44405,4183 K to 5.4 K (+82.18 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseM0.0073800
Mar 14 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...SellS15.6773811,5681,3882.1 K to 1.4 K (-34.71 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...BuyM0.0073802,1261.4 K to 2.1 K (+53.17 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseM0.0088300
Mar 14 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...SellS15.693255,0998,4508.8 K to 8.5 K (-3.70 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...BuyM0.0088308,7757.9 K to 8.8 K (+11.19 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.0095300
Mar 14 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS15.6795314,9380953 to 0 (-100.00 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.0095309530 to 953
Mar 14 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseM0.001,19100
Mar 14 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...SellS15.6764710,1428,6029.2 K to 8.6 K (-7.00 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...BuyM0.001,19109,2498.1 K to 9.2 K (+14.78 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.0071500
Mar 14 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS15.6971511,2180715 to 0 (-100.00 %)
Mar 14 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.0071507150 to 715
Mar 06 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...Option ExerciseA0.0041,791041,791
Mar 06 2019TEVATEVA PHARMACEUTICA ...Schultz KarePresident and CEOOption ExerciseA0.00179,1040179,104
Mar 06 2019TEVATEVA PHARMACEUTICA ...Sabag MarkEVP, Global Human R ...Option ExerciseA0.0047,761047,761
Mar 06 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseA0.0056,716056,716
Mar 06 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseA0.0038,805038,805
Mar 06 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...Option ExerciseA0.0050,746050,746
Mar 06 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseA0.0019,321019,321
Mar 06 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseA0.0056,716056,716
Mar 06 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseA0.0041,791041,791
Mar 06 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...Option ExerciseA0.0074,626074,626
Mar 06 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseA0.0047,761047,761
Mar 06 2019TEVATEVA PHARMACEUTICA ...Codner Iris BeckEVP Global Brand&Co ...Option ExerciseA0.0026,865026,865
Mar 05 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseM0.001,39902,799
Mar 05 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...SellS16.885128,6457,8928.4 K to 7.9 K (-6.09 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...BuyM0.001,39908,4047 K to 8.4 K (+19.97 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseM0.001,16602,332
Mar 05 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...SellS16.881,16619,6861,3882.6 K to 1.4 K (-45.65 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...BuyM0.001,16602,5541.4 K to 2.6 K (+84.01 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...Option ExerciseM0.001,04902,099
Mar 05 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...SellS16.883636,12912,33012.7 K to 12.3 K (-2.86 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...BuyM0.001,049012,69311.6 K to 12.7 K (+9.01 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.002,94108,823
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.001,16602,332
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS16.881,16619,68601.2 K to 0 (-100.00 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS16.882,94149,6541,1664.1 K to 1.2 K (-71.61 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.001,16604,1072.9 K to 4.1 K (+39.65 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.002,94102,9410 to 2.9 K
Mar 05 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.001,16500
Mar 05 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS16.884096,90516,09416.5 K to 16.1 K (-2.48 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.001,165016,50315.3 K to 16.5 K (+7.60 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseM0.001,39902,799
Mar 05 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...SellS16.8860610,2318,0588.7 K to 8.1 K (-6.99 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...BuyM0.001,39908,6647.3 K to 8.7 K (+19.26 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.002,09804,199
Mar 05 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS16.882,09835,42302.1 K to 0 (-100.00 %)
Mar 05 2019TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.002,09802,0980 to 2.1 K
Feb 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...Option ExerciseM0.003,92607,852
Feb 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...SellS17.743,92669,6472,9746.9 K to 3 K (-56.90 %)
Feb 19 2019TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...BuyM0.003,92606,9003 K to 6.9 K (+132.01 %)
Feb 19 2019TEVATEVA PHARMACEUTICA ...Sabag MarkEVP, Global Human R ...Option ExerciseM0.005,710011,422
Feb 19 2019TEVATEVA PHARMACEUTICA ...Sabag MarkEVP, Global Human R ...BuyM0.005,710056,60850.9 K to 56.6 K (+11.22 %)
Feb 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.005,353010,708
Feb 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS17.671,84132,52915,33817.2 K to 15.3 K (-10.72 %)
Feb 19 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.005,353017,17911.8 K to 17.2 K (+45.26 %)
Feb 19 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...Option ExerciseM0.009,280018,560
Feb 19 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...SellS17.673,19256,39918,20921.4 K to 18.2 K (-14.92 %)
Feb 19 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...BuyM0.009,280021,40112.1 K to 21.4 K (+76.56 %)
Feb 19 2019TEVATEVA PHARMACEUTICA ...Codner Iris BeckEVP Global Brand&Co ...Option ExerciseM0.003,21206,425
Feb 19 2019TEVATEVA PHARMACEUTICA ...Codner Iris BeckEVP Global Brand&Co ...BuyM0.003,212017,99614.8 K to 18 K (+21.73 %)
Feb 14 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...Option ExerciseA0.001,20401,204
Feb 14 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...SellS17.885,04190,10812,12117.2 K to 12.1 K (-29.37 %)
Feb 14 2019TEVATEVA PHARMACEUTICA ...de Notaristefani CarloExecutive VP Global ...GrantA0.0014,432017,1622.7 K to 17.2 K (+528.64 %)
Feb 14 2019TEVATEVA PHARMACEUTICA ...Codner Iris BeckEVP Global Brand&Co ...GrantA0.006,494014,7848.3 K to 14.8 K (+78.34 %)
Feb 14 2019TEVATEVA PHARMACEUTICA ...Sabag MarkEVP, Global Human R ...GrantA0.009,381050,89841.5 K to 50.9 K (+22.60 %)
Jan 03 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.004,64004,640
Jan 03 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS15.701,64325,79911,82613.5 K to 11.8 K (-12.20 %)
Jan 03 2019TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.004,640013,4698.8 K to 13.5 K (+52.55 %)

Page:   < prev 1 2 3 4 next >

Contact us | Follow us on Twitter